VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 2 of 34
A New Intervention to Improve Function in Veterans With Anxiety and Depression
NCT06188923
A Study to Improve Skeletal Muscle in Veterans With HIV
NCT06845046
HealthyTogether: RCT of a Dyadic Weight Management Intervention
NCT06619041
Multilevel Intervention for Precision Oncology
NCT06825715
VR Mindfulness Training for Veterans With SCI
NCT06587607
Computational Assessment of GABA Receptor Modulation in PTSD
NCT06852469
Personalized Exercise Treatments for Older Veterans With Motoric Cognitive Risk Syndrome
NCT06451874
Adaptation and Examination of a Trauma-informed Intervention for Pregnant Veterans
NCT06906185
Improving Prosthetic Arms for Amputee: A Better Fit and More Functionality
NCT05990062
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
NCT06745063
Arterial Stiffness and Blood Pressure
NCT06495710
Improving Sleep in Veterans With the Polytrauma Clinical Triad
NCT06477796
COPEWeb Training for Providers
NCT05812131
Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
NCT06607913
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
NCT06454903
Sensory Synchronized Imaging and Neuromodulation
NCT06548113
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
NCT06778434
Pharmacogenomic Informed Statin Prescribing
NCT06568601
Reliability and Validity of Continuous Inter-limb Stability
NCT06987019
Dosing rTMS for Depression Post-SCI
NCT05553353
Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)
NCT06378541
Hearing Aids for Veterans With Functional Hearing Difficulties
NCT06117254
Suicide Risk Interventions
NCT05931289
Enhancing Rehabilitation for Veterans With Serious Mental Illness
NCT06586164
Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
NCT06932237
Pilot Study of Hospital GamePlan4Care
NCT06634368
Fall Risk Identification and Management for Older Veterans
NCT06573983
Resistant Potato Starch to Alleviate GWI
NCT05820893
Smoking Cessation CM for Veterans With or at Risk for Cancer
NCT06432985
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
NCT06088355
Multisensory Augmentation for Post-stroke Standing Balance
NCT05760885
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
NCT04867317
Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder
NCT06399653
Care for Veterans Post-COVID-19
NCT05787379
Fiber and Calcium Absorption in Older Men
NCT06519877
Water-based Activity to Enhance Recovery in Long COVID-19
NCT06142253
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
NCT06470867
Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans
NCT06089746
Mobile Anger Reduction Intervention
NCT06094933
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
NCT06244199
Auricular Neuromodulation in Veterans With Fibromyalgia
NCT06415591
Combining a Smartphone App With Medications to Manage Heavy Drinking
NCT06303778
Relationships of Affect and Neuroinflammation With Clinical Pain in Veterans With Fibromyalgia
NCT06574165
Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease
NCT06405334
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
NCT06529094
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
NCT06194851
Bright Light Therapy for OSA
NCT05917119
Self-Injury Treatment and Recovery in Veterans
NCT05969080
Enhancing Memory in CPT for PTSD
NCT06000475
Increasing Veterans' Social Engagement and Connectedness
NCT06467214
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.